473 filings
Page 4 of 24
SC 13G
zw0pn3yidl9zchhb
29 Jan 20
VistaGen Therapeutics, Inc.
6:02am
8-K
o216ucf p0e9t8xp
27 Jan 20
Entry into a Material Definitive Agreement
12:00am
424B5
oo28jflw24732uq
24 Jan 20
Prospectus supplement for primary offering
5:01pm
8-K
broqgh7wz ijgnp4i9k
27 Dec 19
Regulation FD Disclosure
4:05pm
8-K
81yleneh94kbb0h urim
12 Dec 19
U.S. FDA Grants VistaGen Therapeutics Fast Track Designation for PH94B for Treatment of Social Anxiety Disorder
5:14pm
D
6r56yh k04qa
12 Dec 19
$650K in equity / options, sold $650K, 7 investors
12:00am
4
75657e5
21 Nov 19
VistaGen Therapeutics / H. RALPH SNODGRASS ownership change
7:52pm
8-K
ks1gped7gjz6ktoh5e6
14 Nov 19
VistaGen Reports Topline Phase 2 Results for AV-101 as an Adjunctive Treatment of Major Depressive Disorder
7:46am
8-K
ljeji h43u
8 Nov 19
VistaGen Therapeutics Reports Fiscal 2020 Second Quarter Financial Results and Provides Pipeline Overview
12:00am
8-K
bvowvvsyqda02g zz44
30 Oct 19
Other Events
12:00am
4
3slgc3hu9y7sbmeu
22 Oct 19
VistaGen Therapeutics / JERROLD DUANE DOTSON ownership change
5:02pm
4
109jbc88 ivlf3dw1qgz
22 Oct 19
VistaGen Therapeutics / MARK A. MCPARTLAND ownership change
5:01pm
4
u8y3zw3
22 Oct 19
VistaGen Therapeutics / Mark Alan Smith ownership change
5:01pm
4
1g29e34udl4nhbz
22 Oct 19
VistaGen Therapeutics / H. RALPH SNODGRASS ownership change
5:01pm
4
oqoa7urhjxqymd6 4r
22 Oct 19
VistaGen Therapeutics / Shawn Singh ownership change
5:01pm
4
sy5ch
22 Oct 19
VistaGen Therapeutics / Ann Michelle Cunningham ownership change
5:01pm
4
ehhxdml1d9rx blvkc3
22 Oct 19
VistaGen Therapeutics / Brian J. Underdown ownership change
5:00pm
4
dqg8zkxfb
22 Oct 19
VistaGen Therapeutics / JERRY B GIN ownership change
5:00pm
4
snc9l
22 Oct 19
VistaGen Therapeutics / JON S SAXE ownership change
5:00pm